Pearson (PSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...
The Austin Police Department will be updating its general orders regarding cooperation with ICE and immigration operations ...
At the recent American Academy of Dermatology (AAD) annual meeting, new phase III data from the LATITUDE-PsO-3001 and ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
ISLAMABAD: Major Pakistani airports are maintaining jet fuel reserves of 10 to 12 days, providing the aviation sector with a ...
The UE5 implementation is reportedly 'in progress' and could help developers reduce shader stutter and long load times in ...
Pakistan is facing a sharp rise in fuel import costs as Middle East war disruptions drive diesel premiums to record highs.
TotalEnergies had initially bid $18.88 per mmBtu but later revised its offer downward to $18.4 following negotiations.
He said any positive developments were likely to drive market recovery, particularly given the improved diplomatic status of ...
“Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN ...
TotalEnergies had initially bid $18.88 per mmBtu but later revised its offer downward to $18.4 following negotiations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results